Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells
- PMID: 21931870
- PMCID: PMC3172309
- DOI: 10.1371/journal.pone.0024957
Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells
Abstract
Hepatitis C virus (HCV) is a highly pathogenic human virus associated with liver fibrosis, steatosis, and cancer. In infected cells HCV induces oxidative stress. Here, we show that HCV proteins core, E1, E2, NS4B, and NS5A activate antioxidant defense Nrf2/ARE pathway via several independent mechanisms. This was demonstrated by the analysis of transient co-expression in Huh7 cells of HCV proteins and luciferase reporters. Expression, controlled by the promoters of stress-response genes or their minimal Nrf2-responsive elements, was studied using luminescence assay, RT-qPCR and/or Western-blot analysis. All five proteins induced Nrf2 activation by protein kinase C in response to accumulation of reactive oxygen species (ROS). In addition, expression of core, E1, E2, NS4B, and NS5A proteins resulted in the activation of Nrf2 in a ROS-independent manner. The effect of core and NS5A was mediated through casein kinase 2 and phosphoinositide-3 kinase, whereas those of NS4B, E1, and E2, were not mediated by either PKC, CK2, PI3K, p38, or ERK. Altogether, on the earliest stage of expression HCV proteins induced a strong up-regulation of the antioxidant defense system. These events may underlie the harmful effects of HCV-induced oxidative stress during acute stage of hepatitis C.
Conflict of interest statement
Figures







Similar articles
-
Analysis of the Domains of Hepatitis C Virus Core and NS5A Proteins that Activate the Nrf2/ARE Cascade.Acta Naturae. 2016 Jul-Sep;8(3):123-127. Acta Naturae. 2016. PMID: 27795852 Free PMC article.
-
Hepatitis C Virus Proteins Core and NS5A Are Highly Sensitive to Oxidative Stress-Induced Degradation after eIF2α/ATF4 Pathway Activation.Viruses. 2020 Apr 9;12(4):425. doi: 10.3390/v12040425. Viruses. 2020. PMID: 32283772 Free PMC article.
-
Hepatitis C virus NS5A and core protein induce fibrosis-related genes regulation on Huh7 cells through activation of LX2 cells.Ann Hepatol. 2024 Sep-Oct;29(5):101517. doi: 10.1016/j.aohep.2024.101517. Epub 2024 Jun 7. Ann Hepatol. 2024. PMID: 38852781
-
Legalon-SIL downregulates HCV core and NS5A in human hepatocytes expressing full-length HCV.World J Gastroenterol. 2011 Apr 7;17(13):1694-700. doi: 10.3748/wjg.v17.i13.1694. World J Gastroenterol. 2011. PMID: 21483629 Free PMC article.
-
HCV and oxidative stress in the liver.Viruses. 2013 Jan 28;5(2):439-69. doi: 10.3390/v5020439. Viruses. 2013. PMID: 23358390 Free PMC article. Review.
Cited by
-
Innate immune evasion by filoviruses.Virology. 2015 May;479-480:122-30. doi: 10.1016/j.virol.2015.03.030. Epub 2015 Apr 3. Virology. 2015. PMID: 25843618 Free PMC article. Review.
-
Analysis of the Domains of Hepatitis C Virus Core and NS5A Proteins that Activate the Nrf2/ARE Cascade.Acta Naturae. 2016 Jul-Sep;8(3):123-127. Acta Naturae. 2016. PMID: 27795852 Free PMC article.
-
HIV-1 Reverse Transcriptase Promotes Tumor Growth and Metastasis Formation via ROS-Dependent Upregulation of Twist.Oxid Med Cell Longev. 2019 Dec 2;2019:6016278. doi: 10.1155/2019/6016278. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31885806 Free PMC article.
-
Signaling Induced by Chronic Viral Hepatitis: Dependence and Consequences.Int J Mol Sci. 2022 Mar 3;23(5):2787. doi: 10.3390/ijms23052787. Int J Mol Sci. 2022. PMID: 35269929 Free PMC article. Review.
-
Genetically Modified Mouse Mesenchymal Stem Cells Expressing Non-Structural Proteins of Hepatitis C Virus Induce Effective Immune Response.Vaccines (Basel). 2020 Feb 2;8(1):62. doi: 10.3390/vaccines8010062. Vaccines (Basel). 2020. PMID: 32024236 Free PMC article.
References
-
- Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5:558–567. - PubMed
-
- Nocente R, Ceccanti M, Bertazzoni G, Cammarota G, Silveri NG, et al. HCV infection and extrahepatic manifestations. Hepatogastroenterology. 2003;50:1149–1154. - PubMed
-
- Jacobson IM, Davis GL, El-Serag H, Negro F, Trepo C. Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol. 2010;8:924–933; quiz e117. - PubMed
-
- National Institutes of Health. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements. 2002;19:1–46. - PubMed
-
- Levrero M. Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene. 2006;25:3834–3847. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous